$347 Million is the total value of Alphabet Inc.'s 4 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 33.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ARRS | Arris Intl Inc | $271,892,000 | +5.9% | 9,703,500 | 0.0% | 78.26% | -3.4% | |
SNAP | Snap Inccl a | $47,090,000 | -21.1% | 2,649,930 | 0.0% | 13.55% | -28.1% | |
CLDR | New | Cloudera Inc | $28,340,000 | – | 1,769,033 | +100.0% | 8.16% | – |
TWTR | Sell | Twitter Inc | $117,000 | -73.0% | 6,533 | -77.5% | 0.03% | -75.2% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SPERO THERAPEUTICS INC | 24 | Q3 2023 | 3.5% |
AUTOLUS THERAPEUTICS PLC | 22 | Q3 2023 | 2.8% |
Magenta Therapeutics Inc. | 21 | Q2 2023 | 3.8% |
DEXCOM INC | 20 | Q3 2023 | 17.4% |
Evelo Biosciences Inc. | 20 | Q1 2023 | 1.6% |
ALECTOR INC | 19 | Q3 2023 | 1.1% |
Lyft Inc | 18 | Q2 2023 | 51.9% |
QUINCE THERAPEUTICS INC | 18 | Q3 2023 | 0.6% |
Arcus Biosciences Inc | 17 | Q1 2022 | 12.7% |
FULCRUM THERAPEUTICS INC | 17 | Q3 2023 | 0.7% |
View Alphabet Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
ARRIS International plc | February 14, 2019 | 7,603,500 | 4.4% |
View Alphabet Inc.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
10-Q | 2024-04-26 |
144 | 2024-04-26 |
4 | 2024-04-26 |
4 | 2024-04-26 |
ARS | 2024-04-26 |
DEF 14A | 2024-04-26 |
DEFA14A | 2024-04-26 |
8-K | 2024-04-25 |
144 | 2024-04-17 |
144 | 2024-04-17 |
View Alphabet Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.